Lung Cancer Stage III Clinical Trials

18 clinical trials for Lung Cancer Stage III across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations. — RECRUITING · PHASE2
• Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC — RECRUITING · PHASE2
• Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery — RECRUITING · PHASE2
• Bovine Reinforcement in Stomach, Colorectal and Lung Operation — RECRUITING · PHASE3
• Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC — RECRUITING
• COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) — RECRUITING
• Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC — ACTIVE_NOT_RECRUITING · PHASE2
• Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy — ACTIVE_NOT_RECRUITING
• Induction Chemo-Nivo in Unresectable Stage III NSCLC — TERMINATED · PHASE2
• A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants — WITHDRAWN · PHASE1
• Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) — OTHER
• Resilience Measurement in Older Adults With Late-Stage Lung Cancer — COMPLETED · NA
• Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer — OTHER
• Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management — OTHER · PHASE1
• Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC. — OTHER
• Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer — OTHER · PHASE2
• Self-System Therapy for Older Adults With Lung Cancer — COMPLETED · NA

Refine this search